We are thrilled to be working with these thought-leading surgeons since our initial product launch at NASS. The market response and adoption exceeds our expectations by far. --Guntmar Eisen, CEO
ROSWELL, Ga. (PRWEB) November 28, 2017
Emerging Implant Technologies GmbH (EIT), a German medical device manufacturer exclusively focused on creating innovative technologies for spinal application by utilizing additive manufacturing, announces that it has now performed the first surgeries in the United States and is able to offer all interbody products for Cervical, ALIF, TLIF and PLIF procedures.
EIT Cellular Titanium® is a 3D printed porous titanium structure that has been designed according to scientific insights on ideal pore shape and size to optimize cell proliferation and bone ingrowth.
The first surgeons to implant this novel cage technology were:
- Matthew Gornet, orthopaedic spine surgeon at St. Louis Spine and Orthopedic Surgery Center
- Gurvinder Deol, orthopaedic spine surgeon at Wake Orthopaedics
- Faheem Sandhu, orthopaedic spine surgeon at Georgetown University
- Brandon Scott, orthopaedic spine surgeon at Saint Francis Medical Center
Since that time, EIT has experienced incredible adoption throughout the country and has exceeded initial case volume projections by 250%.
As to why these cages have been so appealing to U.S. surgeons, the initial surgeons have said the following:
Matthew Gornet, MD, a fellowship-trained spine surgeon from Johns Hopkins Hospital as well as author of several published book chapters and research papers said, “I am excited to use this new technology to enhance the outcomes of my patients.”
Dr. Gurvinder S. Deol, MD, is a board certified (FAAOS), fellowship-trained Orthopedic Spine Surgeon for Wake Orthopaedics in Raleigh, NC said “The large surface of cellular porous structure combined with encouraging data from over 15,000 implants throughout Europe and many international markets make a lot of sense to me.”
Faheem Sandhu MD, PhD, is director of spine surgery at MedStar Georgetown University Hospital and professor of neurological surgery at Georgetown University Medical Center said, “I’m very excited about porous titanium cages and the possibility for improving fusion rates while reducing the need for biologic agents.”
Brandon Scott, MD. at Saint Francis Healthcare System is a Neurosurgeon in Cape Girardeau, Missouri. said, “The adaptation of the design of the cervical cage to the cervical anatomy is very nice and allows me to have a perfect fit of the implant with high primary stability.”
“We are thrilled to be working with these thought-leading surgeons since our initial product launch at NASS. The market response and adoption exceeds our expectations by far,” said Guntmar Eisen, cofounder and CEO of EIT.
EIT is the first medical device manufacturer to exclusively focus on implants for spinal alignment, that are designed according to latest published science on optimal bone ingrowth in porous titanium scaffolds and produced with additive manufacturing methods. EIT was founded in 2014 by Hans Eekhof and Guntmar Eisen.
The EIT implants are made of EIT Cellular Titanium®, that addresses the clinical shortcomings of the current cage designs and materials (non-fusion, biocompatibility, subsidence, migration and imaging distortion), thereby obtaining very promising fusion results and improved clinical outcome due to the qualities of the porous 3-D printing of titanium. The highly porous titanium scaffold ensures extensive bone ingrowth as a result of its specific design and elasticity close to the cancellous bone. Due to its unique design with a porosity of 80% the EIT implants ensure uncompromised imaging on X-ray and MRI and enabling excellent follow up on defining bone ingrowth and fusion with CT.
A complete portfolio of Smart Spinal Implants™ based on EIT Cellular Titanium® is available for the cervical and lumbar spine, with an extensive choice in footprint sizes, heights and lordosis angles to support the recreation of sagittal balance and alignment. Since 2014 over 10.000 EIT cases have been performed in over 15 markets globally.